Dr Pierre Meulien

Guest Contributor
October 31, 2010

Dr Pierre Meulien has been appointed president and CEO of Genome Canada, replacing interim president and CEO Dale Patterson and filling a gap that was created by the abrupt departure of Dr Martin Godbout last year (R$, October 26/09). Meulien comes from Genome BC where he served as chief scientific officer for 3.5 years. He has extensive private sector research management experience, including Aventis Pasteur (director of research in Lyon, France and senior VP R&D in Toronto), and Strasbourg-based Transgene. He holds a PhD from the Univ of Edinburgh and completed post-doctoral work at Institut Pasteur in Paris. Patterson returns to his role as Genome Canada's VP external relations….


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.